

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 9.06876584 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 7.54947875 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.00636183 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.00636183 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.73909272 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.73909272 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.25440104 |
| 8 | * drug metabolic process (GO:0017144) | 5.85956325 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.61619083 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.55877490 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.55877490 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.55877490 |
| 13 | cysteine metabolic process (GO:0006534) | 5.42653529 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.42000573 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.37315281 |
| 16 | uronic acid metabolic process (GO:0006063) | 5.35281242 |
| 17 | glucuronate metabolic process (GO:0019585) | 5.35281242 |
| 18 | lysine catabolic process (GO:0006554) | 5.33457723 |
| 19 | lysine metabolic process (GO:0006553) | 5.33457723 |
| 20 | kynurenine metabolic process (GO:0070189) | 5.28154790 |
| 21 | tryptophan metabolic process (GO:0006568) | 5.24260688 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.23626974 |
| 23 | bile acid biosynthetic process (GO:0006699) | 5.20850481 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.14948348 |
| 25 | urea cycle (GO:0000050) | 5.14470611 |
| 26 | urea metabolic process (GO:0019627) | 5.14470611 |
| 27 | ethanol metabolic process (GO:0006067) | 5.00566165 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 4.95550589 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.94814347 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.91273069 |
| 31 | amino-acid betaine metabolic process (GO:0006577) | 4.77550442 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.76799119 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 4.75622622 |
| 34 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.72783259 |
| 35 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.72783259 |
| 36 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.70435665 |
| 37 | angiotensin maturation (GO:0002003) | 4.64615941 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.53836227 |
| 39 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.52915386 |
| 40 | intestinal absorption (GO:0050892) | 4.52527319 |
| 41 | bile acid metabolic process (GO:0008206) | 4.50756608 |
| 42 | regulation of protein activation cascade (GO:2000257) | 4.49706497 |
| 43 | negative regulation of fibrinolysis (GO:0051918) | 4.49092023 |
| 44 | alpha-amino acid catabolic process (GO:1901606) | 4.46785352 |
| 45 | protein carboxylation (GO:0018214) | 4.45266887 |
| 46 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.45266887 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.44803725 |
| 48 | acetyl-CoA metabolic process (GO:0006084) | 4.41582560 |
| 49 | high-density lipoprotein particle remodeling (GO:0034375) | 4.40904933 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.37800999 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.37800999 |
| 52 | complement activation, classical pathway (GO:0006958) | 4.37233680 |
| 53 | fatty acid beta-oxidation (GO:0006635) | 4.34827859 |
| 54 | protein activation cascade (GO:0072376) | 4.30754499 |
| 55 | complement activation (GO:0006956) | 4.29738139 |
| 56 | regulation of fibrinolysis (GO:0051917) | 4.28334952 |
| 57 | short-chain fatty acid metabolic process (GO:0046459) | 4.26849865 |
| 58 | oxidative demethylation (GO:0070989) | 4.26595564 |
| 59 | valine metabolic process (GO:0006573) | 4.25137086 |
| 60 | NADH metabolic process (GO:0006734) | 4.24652052 |
| 61 | regulation of complement activation (GO:0030449) | 4.23825329 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 4.21884342 |
| 63 | cellular amino acid catabolic process (GO:0009063) | 4.21387847 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 4.21276180 |
| 65 | hormone catabolic process (GO:0042447) | 4.20772933 |
| 66 | fatty acid oxidation (GO:0019395) | 4.20464277 |
| 67 | diacylglycerol metabolic process (GO:0046339) | 4.16677298 |
| 68 | drug transmembrane transport (GO:0006855) | 4.15078910 |
| 69 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.14151566 |
| 70 | drug catabolic process (GO:0042737) | 4.13502434 |
| 71 | lipid oxidation (GO:0034440) | 4.12461195 |
| 72 | response to mercury ion (GO:0046689) | 4.11919745 |
| 73 | urate metabolic process (GO:0046415) | 4.07628648 |
| 74 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.07007387 |
| 75 | fatty acid catabolic process (GO:0009062) | 4.04371405 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 4.03853542 |
| 77 | blood coagulation, intrinsic pathway (GO:0007597) | 4.02975732 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 4.00526975 |
| 79 | coenzyme catabolic process (GO:0009109) | 3.97227556 |
| 80 | phenylpropanoid metabolic process (GO:0009698) | 3.96343269 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 3.96048430 |
| 82 | acute-phase response (GO:0006953) | 3.95977584 |
| 83 | glutamate metabolic process (GO:0006536) | 3.95254355 |
| 84 | monocarboxylic acid catabolic process (GO:0072329) | 3.94039614 |
| 85 | positive regulation of lipid catabolic process (GO:0050996) | 3.93264285 |
| 86 | reverse cholesterol transport (GO:0043691) | 3.93044671 |
| 87 | protein-lipid complex remodeling (GO:0034368) | 3.92910953 |
| 88 | macromolecular complex remodeling (GO:0034367) | 3.92910953 |
| 89 | plasma lipoprotein particle remodeling (GO:0034369) | 3.92910953 |
| 90 | carboxylic acid catabolic process (GO:0046395) | 3.91733609 |
| 91 | organic acid catabolic process (GO:0016054) | 3.91733609 |
| 92 | indolalkylamine metabolic process (GO:0006586) | 3.91294031 |
| 93 | regulation of cholesterol esterification (GO:0010872) | 3.89600003 |
| 94 | ethanol oxidation (GO:0006069) | 3.85463316 |
| 95 | biotin metabolic process (GO:0006768) | 3.83508831 |
| 96 | negative regulation of sterol transport (GO:0032372) | 3.83464289 |
| 97 | negative regulation of cholesterol transport (GO:0032375) | 3.83464289 |
| 98 | cholesterol efflux (GO:0033344) | 3.82918892 |
| 99 | carnitine metabolic process (GO:0009437) | 3.81628089 |
| 100 | aspartate family amino acid catabolic process (GO:0009068) | 3.78685462 |
| 101 | opsonization (GO:0008228) | 3.78231720 |
| 102 | glycine metabolic process (GO:0006544) | 3.77872758 |
| 103 | cellular biogenic amine catabolic process (GO:0042402) | 3.77044544 |
| 104 | amine catabolic process (GO:0009310) | 3.77044544 |
| 105 | cellular glucuronidation (GO:0052695) | 3.77023208 |
| 106 | alkaloid metabolic process (GO:0009820) | 3.75608827 |
| 107 | benzene-containing compound metabolic process (GO:0042537) | 3.75222693 |
| 108 | exogenous drug catabolic process (GO:0042738) | 3.74480327 |
| 109 | phospholipid efflux (GO:0033700) | 3.70062573 |
| 110 | fatty acid transmembrane transport (GO:1902001) | 3.69358705 |
| 111 | plasma lipoprotein particle assembly (GO:0034377) | 3.68148498 |
| 112 | fibrinolysis (GO:0042730) | 3.68086329 |
| 113 | branched-chain amino acid catabolic process (GO:0009083) | 3.66312109 |
| 114 | regulation of bile acid biosynthetic process (GO:0070857) | 3.66084595 |
| 115 | bile acid and bile salt transport (GO:0015721) | 3.64402658 |
| 116 | branched-chain amino acid metabolic process (GO:0009081) | 3.64164208 |
| 117 | ketone body metabolic process (GO:1902224) | 3.63877764 |
| 118 | lipoprotein transport (GO:0042953) | 3.62351607 |
| 119 | negative regulation of hemostasis (GO:1900047) | 3.62007383 |
| 120 | negative regulation of blood coagulation (GO:0030195) | 3.62007383 |
| 121 | fructose metabolic process (GO:0006000) | 3.61332697 |
| 122 | serine family amino acid biosynthetic process (GO:0009070) | 3.60626194 |
| 123 | positive regulation of fatty acid oxidation (GO:0046321) | 3.60550495 |
| 124 | phospholipid homeostasis (GO:0055091) | 3.60186426 |
| 125 | negative regulation of lipase activity (GO:0060192) | 3.59394320 |
| 126 | plasma lipoprotein particle organization (GO:0071827) | 3.58640796 |
| 127 | regulation of humoral immune response (GO:0002920) | 3.58305692 |
| 128 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.58215093 |
| 129 | imidazole-containing compound metabolic process (GO:0052803) | 3.57119528 |
| 130 | regulation of cholesterol homeostasis (GO:2000188) | 3.56415458 |
| 131 | negative regulation of protein activation cascade (GO:2000258) | 3.54836451 |
| 132 | lipoprotein metabolic process (GO:0042157) | 3.54573710 |
| 133 | regulation of sequestering of triglyceride (GO:0010889) | 3.53975865 |
| 134 | regulation of plasminogen activation (GO:0010755) | 3.53600237 |
| 135 | arginine metabolic process (GO:0006525) | 3.51945008 |
| 136 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.50867583 |
| 137 | aldehyde catabolic process (GO:0046185) | 3.48102798 |
| 138 | low-density lipoprotein particle clearance (GO:0034383) | 3.47665792 |
| 139 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.45246131 |
| 140 | flavonoid metabolic process (GO:0009812) | 3.45220253 |
| 141 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.44460511 |
| 142 | drug transport (GO:0015893) | 3.44048300 |
| 143 | S-adenosylmethionine metabolic process (GO:0046500) | 3.43062633 |
| 144 | protein-lipid complex subunit organization (GO:0071825) | 3.39371889 |
| 145 | cytolysis (GO:0019835) | 3.38243450 |
| 146 | renal system process involved in regulation of blood volume (GO:0001977) | 3.37057531 |
| 147 | intestinal cholesterol absorption (GO:0030299) | 3.35835783 |
| 148 | triglyceride catabolic process (GO:0019433) | 3.35328871 |
| 149 | cholesterol homeostasis (GO:0042632) | 3.33714797 |
| 150 | protein-lipid complex assembly (GO:0065005) | 3.31765758 |
| 151 | negative regulation of coagulation (GO:0050819) | 3.31398458 |
| 152 | sterol homeostasis (GO:0055092) | 3.28156745 |
| 153 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.26610833 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.85151899 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.45437952 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.68551038 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.13418033 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.89929351 |
| 6 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.82406785 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.40223461 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.87174969 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.43430917 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.29408211 |
| 11 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.28418329 |
| 12 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02414614 |
| 13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.7838357 |
| 14 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95886943 |
| 15 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58617281 |
| 16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.55896213 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.52858887 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52532575 |
| 19 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39305150 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34306499 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.31022812 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30155469 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.28280783 |
| 24 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.21339881 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18262321 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14673908 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13269822 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.07640219 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06658210 |
| 30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03601139 |
| 31 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02563635 |
| 32 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01094880 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99644333 |
| 34 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97346187 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97211114 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95772063 |
| 37 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.92492759 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.92284600 |
| 39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90833286 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.87867692 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87487612 |
| 42 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87092237 |
| 43 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.85543122 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85343572 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.84255076 |
| 46 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.82042206 |
| 47 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.81753386 |
| 48 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81464217 |
| 49 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79175550 |
| 50 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78353417 |
| 51 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76910279 |
| 52 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75786308 |
| 53 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75473651 |
| 54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71866461 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71451423 |
| 56 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.71262487 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.70842595 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69277487 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69277487 |
| 60 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.68876249 |
| 61 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.67545087 |
| 62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.67146582 |
| 63 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.66627950 |
| 64 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66551471 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.66426972 |
| 66 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.66315021 |
| 67 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.65810479 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.65791440 |
| 69 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64154995 |
| 70 | RXR_22108803_ChIP-Seq_LS180_Human | 0.63038468 |
| 71 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.62974616 |
| 72 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.62910791 |
| 73 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.62033814 |
| 74 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61866432 |
| 75 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.61733962 |
| 76 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.61228329 |
| 77 | SA1_27219007_Chip-Seq_Bcells_Human | 0.60878553 |
| 78 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.60707726 |
| 79 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.60640094 |
| 80 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.60395039 |
| 81 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.60038893 |
| 82 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59915858 |
| 83 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.59238004 |
| 84 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58658334 |
| 85 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.58513410 |
| 86 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.58279726 |
| 87 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57034295 |
| 88 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.56951987 |
| 89 | NFYA_21822215_ChIP-Seq_K562_Human | 0.56838894 |
| 90 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.56787062 |
| 91 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.56625562 |
| 92 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56569023 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.56301328 |
| 94 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.55445143 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55377746 |
| 96 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.55242456 |
| 97 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55231274 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.52975120 |
| 99 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.52171088 |
| 100 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.52171088 |
| 101 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51063763 |
| 102 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.50331807 |
| 103 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.50069537 |
| 104 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49357283 |
| 105 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.49185351 |
| 106 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.48437677 |
| 107 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.48389958 |
| 108 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48147609 |
| 109 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.47647984 |
| 110 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47595264 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47281683 |
| 112 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46645680 |
| 113 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.45904422 |
| 114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.45841787 |
| 115 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.44827227 |
| 116 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.44276502 |
| 117 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.43992706 |
| 118 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.43258660 |
| 119 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43125922 |
| 120 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42951980 |
| 121 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.42504264 |
| 122 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.42020132 |
| 123 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.41361548 |
| 124 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.41273493 |
| 125 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.40576543 |
| 126 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.39309515 |
| 127 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.38118821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.59022345 |
| 2 | MP0005360_urolithiasis | 7.54604424 |
| 3 | MP0005365_abnormal_bile_salt | 5.71699519 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.58719648 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.70185279 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.68232647 |
| 7 | MP0003252_abnormal_bile_duct | 3.64167869 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.41439353 |
| 9 | * MP0005332_abnormal_amino_acid | 3.14108521 |
| 10 | MP0003195_calcinosis | 2.88144883 |
| 11 | MP0009840_abnormal_foam_cell | 2.60769021 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.59630599 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.56965700 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.31758969 |
| 15 | * MP0002118_abnormal_lipid_homeostasis | 2.31757240 |
| 16 | MP0005083_abnormal_biliary_tract | 2.28076426 |
| 17 | * MP0000609_abnormal_liver_physiology | 2.15024942 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.06697614 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.89762777 |
| 20 | MP0009643_abnormal_urine_homeostasis | 1.78815627 |
| 21 | MP0003183_abnormal_peptide_metabolism | 1.77238670 |
| 22 | * MP0005670_abnormal_white_adipose | 1.76424263 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.76280593 |
| 24 | MP0001764_abnormal_homeostasis | 1.71865409 |
| 25 | MP0004130_abnormal_muscle_cell | 1.71675293 |
| 26 | MP0003186_abnormal_redox_activity | 1.60458447 |
| 27 | * MP0005666_abnormal_adipose_tissue | 1.53362850 |
| 28 | MP0002876_abnormal_thyroid_physiology | 1.47500397 |
| 29 | MP0003868_abnormal_feces_composition | 1.44505048 |
| 30 | MP0005451_abnormal_body_composition | 1.36451258 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.32600524 |
| 32 | * MP0002971_abnormal_brown_adipose | 1.32466694 |
| 33 | MP0004264_abnormal_extraembryonic_tissu | 1.25839010 |
| 34 | MP0005535_abnormal_body_temperature | 1.21656736 |
| 35 | MP0005636_abnormal_mineral_homeostasis | 1.21172514 |
| 36 | MP0005409_darkened_coat_color | 1.18899125 |
| 37 | MP0001756_abnormal_urination | 1.16478729 |
| 38 | MP0003879_abnormal_hair_cell | 1.16206864 |
| 39 | MP0006036_abnormal_mitochondrial_physio | 1.13979527 |
| 40 | MP0001661_extended_life_span | 1.13476358 |
| 41 | MP0004185_abnormal_adipocyte_glucose | 1.12404762 |
| 42 | * MP0000598_abnormal_liver_morphology | 1.11074212 |
| 43 | MP0003011_delayed_dark_adaptation | 1.10861717 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.09174418 |
| 45 | MP0004043_abnormal_pH_regulation | 1.08378513 |
| 46 | * MP0005334_abnormal_fat_pad | 1.07885281 |
| 47 | MP0004147_increased_porphyrin_level | 1.07598225 |
| 48 | MP0009697_abnormal_copulation | 1.03557651 |
| 49 | MP0002254_reproductive_system_inflammat | 1.01888389 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.01266751 |
| 51 | MP0005647_abnormal_sex_gland | 1.00409426 |
| 52 | MP0009764_decreased_sensitivity_to | 1.00264987 |
| 53 | * MP0002078_abnormal_glucose_homeostasis | 0.99790296 |
| 54 | MP0009763_increased_sensitivity_to | 0.96074174 |
| 55 | MP0000604_amyloidosis | 0.94881752 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 0.92856507 |
| 57 | MP0002136_abnormal_kidney_physiology | 0.91670368 |
| 58 | MP0009379_abnormal_foot_pigmentation | 0.91495619 |
| 59 | * MP0009642_abnormal_blood_homeostasis | 0.90346462 |
| 60 | * MP0005375_adipose_tissue_phenotype | 0.89774772 |
| 61 | MP0003690_abnormal_glial_cell | 0.87841853 |
| 62 | MP0008469_abnormal_protein_level | 0.84375160 |
| 63 | MP0002132_abnormal_respiratory_system | 0.83193773 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 0.80909518 |
| 65 | MP0005448_abnormal_energy_balance | 0.80641835 |
| 66 | MP0003866_abnormal_defecation | 0.80594722 |
| 67 | MP0005166_decreased_susceptibility_to | 0.80265937 |
| 68 | * MP0009115_abnormal_fat_cell | 0.79639294 |
| 69 | MP0005376_homeostasis/metabolism_phenot | 0.76432169 |
| 70 | MP0001664_abnormal_digestion | 0.75227578 |
| 71 | MP0003724_increased_susceptibility_to | 0.73984261 |
| 72 | * MP0002970_abnormal_white_adipose | 0.70985271 |
| 73 | MP0009765_abnormal_xenobiotic_induced | 0.70668294 |
| 74 | MP0000566_synostosis | 0.69158152 |
| 75 | MP0001765_abnormal_ion_homeostasis | 0.68564366 |
| 76 | MP0003959_abnormal_lean_body | 0.65987145 |
| 77 | MP0010368_abnormal_lymphatic_system | 0.65891024 |
| 78 | MP0000477_abnormal_intestine_morphology | 0.63762923 |
| 79 | MP0008438_abnormal_cutaneous_collagen | 0.62620006 |
| 80 | MP0005266_abnormal_metabolism | 0.61940582 |
| 81 | MP0002168_other_aberrant_phenotype | 0.60897059 |
| 82 | MP0005220_abnormal_exocrine_pancreas | 0.60209605 |
| 83 | MP0000230_abnormal_systemic_arterial | 0.59845972 |
| 84 | MP0000678_abnormal_parathyroid_gland | 0.59408778 |
| 85 | MP0005058_abnormal_lysosome_morphology | 0.59314538 |
| 86 | MP0003953_abnormal_hormone_level | 0.59147469 |
| 87 | MP0005408_hypopigmentation | 0.58192582 |
| 88 | MP0003329_amyloid_beta_deposits | 0.57148637 |
| 89 | MP0001663_abnormal_digestive_system | 0.56472752 |
| 90 | MP0006035_abnormal_mitochondrial_morpho | 0.54416156 |
| 91 | MP0002796_impaired_skin_barrier | 0.53789763 |
| 92 | MP0009785_altered_susceptibility_to | 0.53625563 |
| 93 | MP0006138_congestive_heart_failure | 0.52391725 |
| 94 | MP0005395_other_phenotype | 0.51132124 |
| 95 | MP0002249_abnormal_larynx_morphology | 0.49073941 |
| 96 | MP0008961_abnormal_basal_metabolism | 0.48204532 |
| 97 | MP0003638_abnormal_response/metabolism_ | 0.47995601 |
| 98 | MP0002928_abnormal_bile_duct | 0.47810986 |
| 99 | MP0001501_abnormal_sleep_pattern | 0.47042554 |
| 100 | MP0001881_abnormal_mammary_gland | 0.45792411 |
| 101 | MP0008872_abnormal_physiological_respon | 0.45515882 |
| 102 | MP0009672_abnormal_birth_weight | 0.45298210 |
| 103 | * MP0005452_abnormal_adipose_tissue | 0.42396401 |
| 104 | MP0001845_abnormal_inflammatory_respons | 0.41580669 |
| 105 | MP0005381_digestive/alimentary_phenotyp | 0.41036332 |
| 106 | MP0008874_decreased_physiological_sensi | 0.40650952 |
| 107 | MP0003075_altered_response_to | 0.40369148 |
| 108 | MP0000003_abnormal_adipose_tissue | 0.39502281 |
| 109 | MP0010352_gastrointestinal_tract_polyps | 0.39469172 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.38713120 |
| 111 | MP0000013_abnormal_adipose_tissue | 0.38397831 |
| 112 | MP0002135_abnormal_kidney_morphology | 0.37982987 |
| 113 | MP0009053_abnormal_anal_canal | 0.37177228 |
| 114 | MP0000467_abnormal_esophagus_morphology | 0.37061010 |
| 115 | MP0002909_abnormal_adrenal_gland | 0.36813424 |
| 116 | MP0000639_abnormal_adrenal_gland | 0.36759097 |
| 117 | MP0003718_maternal_effect | 0.36561636 |
| 118 | MP0002822_catalepsy | 0.36166806 |
| 119 | MP0005275_abnormal_skin_tensile | 0.36131097 |
| 120 | MP0002060_abnormal_skin_morphology | 0.35536300 |
| 121 | MP0008873_increased_physiological_sensi | 0.34815774 |
| 122 | MP0000249_abnormal_blood_vessel | 0.34601841 |
| 123 | MP0005167_abnormal_blood-brain_barrier | 0.34117091 |
| 124 | MP0000538_abnormal_urinary_bladder | 0.33606514 |
| 125 | MP0002896_abnormal_bone_mineralization | 0.32927118 |
| 126 | MP0010234_abnormal_vibrissa_follicle | 0.32597582 |
| 127 | MP0005164_abnormal_response_to | 0.31885687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.42761756 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.93910533 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.90285720 |
| 4 | Xanthomatosis (HP:0000991) | 5.78735199 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.57784967 |
| 6 | Hyperglycinuria (HP:0003108) | 5.36074432 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.00625995 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.96888350 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.91077138 |
| 10 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.88951912 |
| 11 | Abnormality of glycine metabolism (HP:0010895) | 4.88951912 |
| 12 | Complement deficiency (HP:0004431) | 4.88110400 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.85849172 |
| 14 | Hyperammonemia (HP:0001987) | 4.82285089 |
| 15 | Ketosis (HP:0001946) | 4.71820913 |
| 16 | Hyperglycinemia (HP:0002154) | 4.59225743 |
| 17 | Epidermoid cyst (HP:0200040) | 4.22422034 |
| 18 | Metabolic alkalosis (HP:0200114) | 4.14874311 |
| 19 | Hyperactive renin-angiotensin system (HP:0000841) | 4.14012844 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.13531514 |
| 21 | Hypoglycemic coma (HP:0001325) | 4.10631557 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.08026936 |
| 23 | Hypolipoproteinemia (HP:0010981) | 4.07253997 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.92831579 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.90502222 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.84381310 |
| 27 | Joint hemorrhage (HP:0005261) | 3.83849906 |
| 28 | Ketoacidosis (HP:0001993) | 3.78356720 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 3.58467642 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 3.57549689 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.56290863 |
| 32 | Gout (HP:0001997) | 3.55472887 |
| 33 | Abnormality of complement system (HP:0005339) | 3.49209370 |
| 34 | Abnormality of purine metabolism (HP:0004352) | 3.43312145 |
| 35 | Abnormality of nucleobase metabolism (HP:0010932) | 3.35499016 |
| 36 | Nephritis (HP:0000123) | 3.35399235 |
| 37 | Fat malabsorption (HP:0002630) | 3.26944805 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.22320874 |
| 39 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.21141159 |
| 40 | Dicarboxylic aciduria (HP:0003215) | 3.21141159 |
| 41 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.19872757 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.16291575 |
| 43 | Delayed CNS myelination (HP:0002188) | 3.13397280 |
| 44 | Increased circulating renin level (HP:0000848) | 3.09554441 |
| 45 | Potter facies (HP:0002009) | 3.04689872 |
| 46 | Facial shape deformation (HP:0011334) | 3.04689872 |
| 47 | Metabolic acidosis (HP:0001942) | 2.99382731 |
| 48 | Generalized aminoaciduria (HP:0002909) | 2.99360071 |
| 49 | Hydroxyprolinuria (HP:0003080) | 2.97461992 |
| 50 | Abnormality of proline metabolism (HP:0010907) | 2.97461992 |
| 51 | Abnormality of the intrinsic pathway (HP:0010989) | 2.96043335 |
| 52 | Conjugated hyperbilirubinemia (HP:0002908) | 2.93004252 |
| 53 | Lethargy (HP:0001254) | 2.88781117 |
| 54 | Proximal tubulopathy (HP:0000114) | 2.87583370 |
| 55 | Hyperbilirubinemia (HP:0002904) | 2.82335479 |
| 56 | Myocardial infarction (HP:0001658) | 2.77624696 |
| 57 | Hepatocellular carcinoma (HP:0001402) | 2.76815379 |
| 58 | Abnormality of vitamin metabolism (HP:0100508) | 2.76394330 |
| 59 | Abnormality of renin-angiotensin system (HP:0000847) | 2.74604019 |
| 60 | Increased purine levels (HP:0004368) | 2.74083522 |
| 61 | Hyperuricemia (HP:0002149) | 2.74083522 |
| 62 | Skin nodule (HP:0200036) | 2.63415573 |
| 63 | Ileus (HP:0002595) | 2.58972032 |
| 64 | Widely patent fontanelles and sutures (HP:0004492) | 2.58353788 |
| 65 | Alkalosis (HP:0001948) | 2.57094437 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 2.56497619 |
| 67 | Cerebral edema (HP:0002181) | 2.56475449 |
| 68 | Abnormality of chloride homeostasis (HP:0011422) | 2.55607426 |
| 69 | Vascular calcification (HP:0004934) | 2.51853971 |
| 70 | Hyperphosphaturia (HP:0003109) | 2.50589768 |
| 71 | Hyperaldosteronism (HP:0000859) | 2.48667179 |
| 72 | Vomiting (HP:0002013) | 2.47720322 |
| 73 | Pancreatitis (HP:0001733) | 2.43100893 |
| 74 | Hypertriglyceridemia (HP:0002155) | 2.42399357 |
| 75 | Spastic diplegia (HP:0001264) | 2.41014900 |
| 76 | Irritability (HP:0000737) | 2.39492212 |
| 77 | Steatorrhea (HP:0002570) | 2.36249743 |
| 78 | Enlarged kidneys (HP:0000105) | 2.35891026 |
| 79 | Hypoglycemic seizures (HP:0002173) | 2.32963280 |
| 80 | Pigmentary retinal degeneration (HP:0001146) | 2.30908395 |
| 81 | Neonatal onset (HP:0003623) | 2.30185822 |
| 82 | Cardiovascular calcification (HP:0011915) | 2.29945043 |
| 83 | Spontaneous abortion (HP:0005268) | 2.28011284 |
| 84 | Hypophosphatemia (HP:0002148) | 2.27619863 |
| 85 | Hypokalemia (HP:0002900) | 2.27013253 |
| 86 | Abnormal urine phosphate concentration (HP:0012599) | 2.25221637 |
| 87 | Confusion (HP:0001289) | 2.24400934 |
| 88 | Focal segmental glomerulosclerosis (HP:0000097) | 2.22522476 |
| 89 | Abnormality of urine glucose concentration (HP:0011016) | 2.21921304 |
| 90 | Glycosuria (HP:0003076) | 2.21921304 |
| 91 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.20904072 |
| 92 | Malnutrition (HP:0004395) | 2.20598376 |
| 93 | Gingival bleeding (HP:0000225) | 2.18759144 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 2.18311073 |
| 95 | Hemorrhage of the eye (HP:0011885) | 2.15551792 |
| 96 | Nausea (HP:0002018) | 2.13927761 |
| 97 | Abnormality of magnesium homeostasis (HP:0004921) | 2.12817094 |
| 98 | Abnormal cartilage morphology (HP:0002763) | 2.12018623 |
| 99 | Osteomalacia (HP:0002749) | 2.11813549 |
| 100 | Abnormality of vitamin B metabolism (HP:0004340) | 2.11538973 |
| 101 | Abdominal distention (HP:0003270) | 2.11288673 |
| 102 | Brushfield spots (HP:0001088) | 2.09945957 |
| 103 | Late onset (HP:0003584) | 2.09612476 |
| 104 | Amyloidosis (HP:0011034) | 2.08870825 |
| 105 | Mitral stenosis (HP:0001718) | 2.04606107 |
| 106 | Myoglobinuria (HP:0002913) | 2.02360585 |
| 107 | Glomerulonephritis (HP:0000099) | 2.00887237 |
| 108 | Abnormal gallbladder morphology (HP:0012437) | 2.00477184 |
| 109 | Rickets (HP:0002748) | 2.00311742 |
| 110 | Hypophosphatemic rickets (HP:0004912) | 1.98572919 |
| 111 | Cholelithiasis (HP:0001081) | 1.97842575 |
| 112 | Esophageal varix (HP:0002040) | 1.96713947 |
| 113 | Hypotension (HP:0002615) | 1.96050331 |
| 114 | Oligomenorrhea (HP:0000876) | 1.95893329 |
| 115 | Renal cortical cysts (HP:0000803) | 1.95848863 |
| 116 | Megaloblastic anemia (HP:0001889) | 1.95712914 |
| 117 | Hypochromic microcytic anemia (HP:0004840) | 1.95003081 |
| 118 | Abnormal urine output (HP:0012590) | 1.94893936 |
| 119 | Elevated alkaline phosphatase (HP:0003155) | 1.94458626 |
| 120 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.94441825 |
| 121 | Acanthocytosis (HP:0001927) | 1.93203388 |
| 122 | Nephrolithiasis (HP:0000787) | 1.92203464 |
| 123 | Cerebral palsy (HP:0100021) | 1.90103388 |
| 124 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89651737 |
| 125 | Thrombophlebitis (HP:0004418) | 1.88931855 |
| 126 | Elevated hepatic transaminases (HP:0002910) | 1.84946361 |
| 127 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.84278295 |
| 128 | Abnormal gallbladder physiology (HP:0012438) | 1.83302582 |
| 129 | Cholecystitis (HP:0001082) | 1.83302582 |
| 130 | Opisthotonus (HP:0002179) | 1.79456194 |
| 131 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.76643797 |
| 132 | Hyperglycemia (HP:0003074) | 1.75647243 |
| 133 | Hypokalemic alkalosis (HP:0001949) | 1.73621026 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.10691718 |
| 2 | ACVR1B | 4.90133186 |
| 3 | SIK1 | 4.29940772 |
| 4 | FGFR4 | 3.53834291 |
| 5 | ERN1 | 3.53636066 |
| 6 | TRIB3 | 3.06865492 |
| 7 | CAMK1D | 2.88849955 |
| 8 | INSRR | 2.86326900 |
| 9 | MST1R | 2.54615829 |
| 10 | EPHA2 | 2.45908084 |
| 11 | WNK4 | 2.21539484 |
| 12 | PRKG2 | 1.99155032 |
| 13 | PDK4 | 1.97815118 |
| 14 | PDK3 | 1.97815118 |
| 15 | WNK3 | 1.96061646 |
| 16 | CAMK1G | 1.94973891 |
| 17 | ERBB4 | 1.93229599 |
| 18 | OXSR1 | 1.69429103 |
| 19 | PRKAA2 | 1.63499964 |
| 20 | FRK | 1.63173815 |
| 21 | PKN2 | 1.60921532 |
| 22 | MAPK11 | 1.59812490 |
| 23 | TAOK3 | 1.57912811 |
| 24 | MAP2K4 | 1.57637587 |
| 25 | LATS1 | 1.55747729 |
| 26 | MAP3K2 | 1.39147150 |
| 27 | RIPK1 | 1.37188974 |
| 28 | FGFR2 | 1.36799893 |
| 29 | DDR2 | 1.32076816 |
| 30 | STK38L | 1.31202095 |
| 31 | PINK1 | 1.28555334 |
| 32 | NLK | 1.23769530 |
| 33 | FLT3 | 1.22719729 |
| 34 | ABL2 | 1.21076660 |
| 35 | PDK2 | 1.18498524 |
| 36 | NEK9 | 1.16915270 |
| 37 | AKT3 | 1.15373074 |
| 38 | PTK6 | 1.10802580 |
| 39 | TIE1 | 1.09897194 |
| 40 | TYK2 | 1.08250129 |
| 41 | JAK2 | 1.06661140 |
| 42 | DAPK2 | 1.02086379 |
| 43 | MAP3K7 | 0.99900393 |
| 44 | PIK3CG | 0.98294197 |
| 45 | JAK1 | 0.97296600 |
| 46 | PRKAA1 | 0.96753977 |
| 47 | MET | 0.94321960 |
| 48 | MAP3K1 | 0.91465557 |
| 49 | TGFBR2 | 0.91082795 |
| 50 | KDR | 0.89305372 |
| 51 | FGFR3 | 0.86617400 |
| 52 | GSK3A | 0.85373916 |
| 53 | CDK6 | 0.84496825 |
| 54 | SGK3 | 0.84479128 |
| 55 | MAP2K3 | 0.84029157 |
| 56 | EPHA4 | 0.82650019 |
| 57 | EPHB1 | 0.81695520 |
| 58 | SGK223 | 0.81566472 |
| 59 | SGK494 | 0.81566472 |
| 60 | PDPK1 | 0.81147052 |
| 61 | GRK6 | 0.79211102 |
| 62 | PRKACG | 0.78378093 |
| 63 | MAP3K3 | 0.77657446 |
| 64 | MAP3K12 | 0.77067027 |
| 65 | IRAK3 | 0.76827082 |
| 66 | PRPF4B | 0.75584198 |
| 67 | PRKCZ | 0.73272525 |
| 68 | MAPK4 | 0.70941830 |
| 69 | STK39 | 0.69287684 |
| 70 | MAPK12 | 0.65686225 |
| 71 | TBK1 | 0.64366572 |
| 72 | SGK2 | 0.63707621 |
| 73 | ERBB2 | 0.62607565 |
| 74 | CSK | 0.62267915 |
| 75 | CAMKK2 | 0.59789299 |
| 76 | MAP2K2 | 0.59046973 |
| 77 | MAP2K1 | 0.56168696 |
| 78 | CDC42BPA | 0.56049773 |
| 79 | KSR2 | 0.55849012 |
| 80 | PDK1 | 0.55354659 |
| 81 | MAP3K6 | 0.55171262 |
| 82 | MAP3K14 | 0.54890103 |
| 83 | PIK3CA | 0.50931880 |
| 84 | MAP3K10 | 0.49886942 |
| 85 | NTRK3 | 0.49724130 |
| 86 | MATK | 0.48845641 |
| 87 | SRC | 0.48592859 |
| 88 | IGF1R | 0.48487817 |
| 89 | MTOR | 0.47760588 |
| 90 | PDGFRA | 0.47626020 |
| 91 | DYRK1B | 0.47232151 |
| 92 | EPHA3 | 0.47151739 |
| 93 | PRKCA | 0.46483257 |
| 94 | PTK2 | 0.45524118 |
| 95 | PRKACA | 0.44922205 |
| 96 | STK24 | 0.43958171 |
| 97 | PRKG1 | 0.43421532 |
| 98 | YES1 | 0.42085304 |
| 99 | LMTK2 | 0.40855590 |
| 100 | STK38 | 0.38703402 |
| 101 | EPHB2 | 0.38414437 |
| 102 | CSF1R | 0.38107480 |
| 103 | CDK4 | 0.37617994 |
| 104 | CAMK2G | 0.37512044 |
| 105 | RET | 0.37140832 |
| 106 | NEK1 | 0.36174135 |
| 107 | NEK6 | 0.35407383 |
| 108 | IRAK2 | 0.35177002 |
| 109 | PRKCH | 0.34119336 |
| 110 | IRAK1 | 0.33908313 |
| 111 | MAPK15 | 0.33561627 |
| 112 | MAP3K11 | 0.32969660 |
| 113 | CSNK1G1 | 0.31613993 |
| 114 | SGK1 | 0.30835506 |
| 115 | FER | 0.29630002 |
| 116 | ICK | 0.29137973 |
| 117 | MAPK7 | 0.28139085 |
| 118 | MAP2K6 | 0.27867844 |
| 119 | TESK1 | 0.27863800 |
| 120 | EEF2K | 0.26993036 |
| 121 | LATS2 | 0.25565618 |
| 122 | PRKCQ | 0.25409477 |
| 123 | MAPK3 | 0.24955744 |
| 124 | MYLK | 0.24920434 |
| 125 | CAMK2D | 0.24575049 |
| 126 | BMX | 0.24395689 |
| 127 | MAPKAPK3 | 0.24176593 |
| 128 | CSNK1A1 | 0.24027329 |
| 129 | IKBKE | 0.23985896 |
| 130 | CDK9 | 0.22917677 |
| 131 | GRK1 | 0.19616126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.85872061 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.38385298 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.13191785 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.01445560 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.89521872 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.83644701 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.83581156 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79178597 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.72463608 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62074957 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.52840166 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40845085 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.40831433 |
| 14 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 2.29460694 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.27068024 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.26692396 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.25140092 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24281471 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.07480196 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.93361884 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88856142 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.75726578 |
| 23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68571599 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67549147 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.65203787 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.64399440 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.64220377 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61721623 |
| 29 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 1.61332679 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59064901 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57794139 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51325765 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50189396 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.45783976 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.44446025 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.43301214 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.41877208 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36958778 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35241365 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34632538 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30452311 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.23350867 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22611580 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22015434 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19268298 |
| 46 | * Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.17665057 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17081781 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14376889 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.11639448 |
| 50 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.11497795 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11343327 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07977462 |
| 53 | * Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01773731 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97615217 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.91878762 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89953225 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.85746707 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83574868 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79367295 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79122575 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78726949 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.74911783 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73328315 |
| 64 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69706967 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68610721 |
| 66 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47846575 |
| 67 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42555542 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41806678 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38652992 |
| 70 | * Insulin resistance_Homo sapiens_hsa04931 | 0.34200530 |
| 71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28626009 |
| 72 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27950218 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.26366351 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25695374 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25186568 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24888916 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.22848345 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.20850911 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.19394174 |
| 80 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18204571 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.16852565 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.13695531 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13590259 |
| 84 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11133942 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.06740048 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.06078929 |
| 87 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02796677 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02184078 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.01877059 |
| 90 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.01415718 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.00752945 |
| 92 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.2008260 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1954639 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1877077 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1800936 |
| 96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1691830 |
| 97 | Lysosome_Homo sapiens_hsa04142 | -0.1612573 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | -0.1565499 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1383523 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | -0.1082596 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1020511 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0876128 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0840643 |
| 104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0834022 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0802980 |
| 106 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0697847 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0612017 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0554576 |
| 109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0544491 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0485302 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0162460 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | -0.0085249 |

